Press Releases on December 7, 2023 - EIN Presswire - Press Release Distribution Service

Published on December 7, 2023 - 13:00 GMT

Kratos Demonstrates 100% Interoperability Success Using the DIFI Standard for Satellite Ground Technology at Industry Event

SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security and global markets, announced today that it demonstrated 100% interoperability success at the …

Distribution channels:

Published on December 7, 2023 - 13:00 GMT

Pixalate Publishes Global Benchmark Report for Made For Advertising (MFA) Websites: Google Sold Ads On 93% of MFA Sites in October ...

London, UK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the October 2023 Made For Advertising (MFA) Benchmark Report for Websites. The report …

Distribution channels: Media, Advertising & PR, Science ...

Published on December 7, 2023 - 13:00 GMT

ABM Expands Partnership with LaGuardia Gateway Partners, Providing Integrated Facility Services for LaGuardia Airport Terminal B

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ABM (NYSE: ABM), a leading provider of comprehensive facility services, infrastructure solutions, and parking management, is proud to announce the expansion of its relationship with LaGuardia Gateway Partners (“ …

Distribution channels: Companies, Media, Advertising & PR ...

Published on December 7, 2023 - 13:00 GMT

Millennium Group International Holdings Named Best Printing and Packaging Manufacturer of the Year by HKCT

HONG KONG, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Millennium Group International Holdings Limited (Nasdaq: MGIH) (the "Company" or "Millennium"), a long-established paper-based packaging solutions supplier, is pleased to announce that the …

Distribution channels: Agriculture, Farming & Forestry Industry ...

Published on December 7, 2023 - 13:00 GMT

Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual ...

First in class, multi-specific CD73/PD-1 inhibitor DFC, exhibited robust anti-tumor activity in humanized mouse models of colorectal cancer at low doses CD73/PD-1 DFC demonstrated superior anti-tumor activity to CD73 and PD-1 monotherapies SAN …

Distribution channels: Technology ...

Published on December 7, 2023 - 13:00 GMT

Fiverr Declares Montserrat 2024 'Font of the Year'

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is changing how the world works together, today announced Montserrat as ‘Font of the Year' for 2024, in association with Fiverr Logo Maker. An analysis …

Distribution channels: Business & Economy, Media, Advertising & PR ...

Published on December 7, 2023 - 13:00 GMT

Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1, a Novel Intravaginal ...

SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for DARE- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on December 7, 2023 - 13:00 GMT

LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc.™ (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the RWJBarnabas Health Telehealth Symposium on Thursday, December 14 from 10:00 a.m. – 1:00 p.m. EST. …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on December 7, 2023 - 13:00 GMT

BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea

BURLINGTON, Mass. and JERUSALEM, Dec. 07, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on December 7, 2023 - 13:00 GMT

IZEA Acquires Advocate Marketing Platform Zuberance

ORLANDO, Fla., Dec. 07, 2023 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands and agencies, today announced it acquired Zuberance, a …

Distribution channels: Media, Advertising & PR ...

Published on December 7, 2023 - 13:00 GMT

Qu Expands Leadership Team with the Addition of Two Key Executives

BETHESDA, Md., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Qu, the unified commerce platform built for enterprise-scale, quick service and fast casual restaurants, announced that it has added two new executives to its management team. John Morrison, formerly an …

Distribution channels: Companies, Technology ...

Published on December 7, 2023 - 13:00 GMT

Immutep Receives A$2.6 million R&D Tax Incentive from French Government

Media Release SYDNEY, AUSTRALIA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune …

Distribution channels: Technology ...

Published on December 7, 2023 - 13:00 GMT

Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds

MARLBOROUGH, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor …

Distribution channels: ...

Published on December 7, 2023 - 13:00 GMT

Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma

VIPER-101 is an autologous, CD5 knock-out CAR-T therapy for the treatment of T-cell lymphoma Initiating first-in-human Phase 1 trial in H1 of 2024 PHILADELPHIA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics has announced the clearance of an …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on December 7, 2023 - 13:00 GMT

TechFlow Secures 7-Year $2.1 Billion TSA Contract for Explosives Detection System Upkeep at Over 300 Facilities Spanning the U.S. ...

SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- TechFlow, a 100% employee-owned forward-thinking energy, mobility, logistics, and digital solutions company, today announced a landmark seven-year contract with the Transportation Security Administration (TSA) …

Distribution channels: Business & Economy, Technology ...

Published on December 7, 2023 - 13:00 GMT

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE ...

The final histopathology and lab report supplements previous positive Company findings. The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study. BRAINTREE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 7, 2023 - 13:00 GMT

MedBright AI Announces Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform

VANCOUVER, British Columbia, Dec. 07, 2023 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) is pleased to announce that the Dermatology Institute & Skin Care Center (“DISCC”), a leader in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on December 7, 2023 - 13:00 GMT

Sharecare wins 22 Digital Health Awards in Fall 2023 competition

ATLANTA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced it has won 22 Digital Health Awards in the Health Information Resource Center’s Fall …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 7, 2023 - 13:00 GMT

Perspective Therapeutics Announces First Patient Dosed in a Phase 1 Study of [(212)Pb]VMT-α-NET to Treat Refractory or Relapsed ...

First U.S. patient with refractory or relapsed SSTR2-positive neuroendocrine tumors treated with [212Pb]VMT-α-NET Preliminary data readout expected in second half of 2024 SEATTLE, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on December 7, 2023 - 13:00 GMT

Spod Lithium Completes Phase 1 of Its Exploration Program at Its Lithium Grande 4 and Megali Lithium Projects in James Bay Quebec

Highlights: 25 days of fieldwork exploration were completed over both properties. A total of 229 rock-chip samples were taken over the 2 properties and have been sent to ALS Laboratories for alkaline fusion assaying with results pending. An aeromagnetic, …

Distribution channels: Banking, Finance & Investment Industry, Mining Industry ...